(₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 27.57 | 34.95 | 28.47 | -21.1% | -3.2% |
Total Expenses | 20.91 | 26.05 | 20.52 | -19.7% | 1.9% |
Profit Before Tax | 6.67 | 8.90 | 7.96 | -25.1% | -16.2% |
Tax | 3.12 | 0.00 | 3.31 | - | -5.7% |
Profit After Tax | 3.55 | 8.90 | 4.65 | -60.1% | -23.7% |
Earnings Per Share | 1.70 | 4.20 | 2.10 | -59.5% | -19.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Alpa Laboratories Ltd is a company whose primary business operations and industry classification are not specified in the provided data. There is no detailed information available regarding the main products or services offered by Alpa Laboratories Ltd, nor are there any recent major developments mentioned. Without these specifics, the company’s strategic focus, market position, or changes in its business environment remain unaddressed.
During Q4FY25, Alpa Laboratories Ltd reported a total income of ₹27.57 crores, a decrease of 21.1% from the previous quarter (Q3FY25) where the income was ₹34.95 crores. When compared to the same quarter in the previous year (Q4FY24), the income showed a decline of 3.2% from ₹28.47 crores. The year-over-year (YoY) and quarter-over-quarter (QoQ) changes indicate fluctuations in revenue within the timeframe, marking a decrease in both cases.
The Profit Before Tax (PBT) for Q4FY25 was ₹6.67 crores, showing a decrease of 25.1% from the previous quarter's ₹8.90 crores and a decline of 16.2% from ₹7.96 crores in Q4FY24. The company’s tax expenses for Q4FY25 amounted to ₹3.12 crores, which showed no change from Q3FY25 due to unavailable data, but showed a decrease of 5.7% from the previous year's same quarter. Profit After Tax (PAT) dropped significantly by 60.1% quarter-over-quarter from ₹8.90 crores in Q3FY25 to ₹3.55 crores in Q4FY25, and also showed a year-over-year decrease of 23.7% compared to ₹4.65 crores in Q4FY24. Earnings Per Share (EPS) followed a similar trend, declining by 59.5% QoQ from ₹4.20 to ₹1.70 and by 19.0% YoY from ₹2.10.
The total expenses reported in Q4FY25 were ₹20.91 crores, reflecting a decrease of 19.7% from the previous quarter's ₹26.05 crores. When compared to the same quarter in the previous year, expenses showed a slight increase of 1.9% from ₹20.52 crores. This suggests a cost structure that has seen reduction quarter over quarter but remains slightly elevated year over year. The financial data demonstrates fluctuations in key operating metrics, including a reduction in income and profitability metrics across the board, indicating a variance in the company's financial performance over the specified periods.